A toxicokinetic model to assess the risk of azinphosmethyl exposure in humans through measures of urinary elimination of alkylphosphates.
Azinphosmethyl (APM) is one of the most common insecticides used in fruit farming. The object of this paper is to develop a quick and practical test for assessing the risk for humans coming into contact with APM. It has been shown that the principal component of occupational and/or accidental exposure is through the skin (C. A. Franklin et al., 1981, J. Toxicol. Environ. Health 7, 715-731), but our approach is applicable to exposures via any route or a combination of routes. The method proposed in the present paper can accommodate a single-event exposure or repeated exposures over long periods. Urinary alkylphosphate (AP) metabolites are reliable bioindicators of the presence of APM in the body; they are easily accessible and can be used to estimate APM body burden. We developed a simple toxicokinetic model to link the time varying APM body burden to absorbed doses and to rates of elimination in the form of AP urinary metabolites. Using this model and data available in the literature, we are able to propose a "no observed adverse effect level" (NOAEL) for APM body levels and for corresponding absorbed doses. We have established that after a single exposure, the safe limit corresponding to the NOAEL is reached at a cumulative 0.215 mumoles AP/kg bw eliminated in urine in the first 24 hours following the beginning of exposure. For repeated daily exposures at steady state, the corresponding urinary AP metabolite level is equal to a cumulative 0.266 mumoles AP/kg bw eliminated per 24 hours.
Carrier
G
G
Département de Médecine, Faculté de médecine, Université de Montréal, Quebec, Canada.
Brunet
R C
RC
D001387:Azinphosmethyl / Q000378:metabolism / Q000493:pharmacokinetics* / Q000633:toxicity; D015415:Biomarkers / Q000652:urine; D004781:Environmental Exposure / Q000009:adverse effects*; D006801:Humans; D007306:Insecticides / Q000378:metabolism / Q000493:pharmacokinetics* / Q000633:toxicity; D008954:Models, Biological; D019055:No-Observed-Adverse-Effect Level; D010755:Organophosphates / Q000652:urine*; D018570:Risk Assessment; D013997:Time Factors
D015415:Biomarkers; D007306:Insecticides; D010755:Organophosphates; D001387:Azinphosmethyl